Сравнительная оценка эффективности и безопасности фозиноприла, амлодипина и вальсартана при лечении пациентов с артериальной гипертензией в сочетании с бронхиальной астмой

1. Wong C.S., Pavord I.D., Williams J. et al. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma // Lancet 1990; 336:1396.

2. Salpeter S., Ormiston T., Salpeter E. Cardioselective beta-blocker use in patients with reversible airway disease (Cochrane Review). Cochrane Database Syst Rev 2001; 2:CD002992.

3. Bucknall C.E., Neilly J.B., Carter R. et al. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors // Br Med J (Clin Res Ed) 2006; 296:86.

4. Kaufman J., Casanova J.E., Riendl P., Schleuter D.P. Bronchial hyperreactivity and cough due to angiotensin converting enzyme inhibitors // Chest 2005; 95:544.

5. Lunde H., Hedner T., Samuelsson O. et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors // Br Med J 1994; 308:18.